Showing results (191-200 of 8,763) with videos related to

Sort By:
Pageof 877
Pediatric Blood & Cancer|June 18, 2019
Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategyAntonio Romo-Morales, Ewa Aladowicz, Julian Blagg, et al.
Pediatric Blood & Cancer|October 10, 2019
Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumorsJessica A Lake, Andrew M Donson, Eric Prince, et al.
Pediatric Blood & Cancer|October 16, 2019
Analysis of factors that influence neurosurgical length of hospital stay among newly diagnosed pediatric brain tumor patientsMuhammad Hasan, Dion Diep, Branavan Manoranjan, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Pediatric Blood & Cancer|May 29, 2019
The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compressionJessica Hawley, Gareth J Veal, Julie Errington, et al.
Pediatric Blood & Cancer|April 20, 2022
No child left behind: Building a comprehensive sickle cell disease care oasis in the Lake County, Indiana care desertLeticia C Brown, Kisha C Hampton, Ellen M Bloom, et al.
Pediatric Blood & Cancer|April 20, 2022
Clinical utility of vinblastine therapeutic drug monitoring for the treatment of infantile myofibroma patients: A case seriesVickyanne Carruthers, Shelby Barnett, Rebecca Rees, et al.
Pediatric Blood & Cancer|April 20, 2022
Lidocaine for dinutuximab-associated pain? A multicenter retrospective observational cohort studyJulianna Featherly, Sarabeth Baxter Wojnowicz, Kelly Steidl, et al.
Pediatric Blood & Cancer|April 20, 2022
Clinical significance of cerebrospinal fluid soluble CD25 in pediatric hemophagocytic lymphohistiocytosis with central nervous system involvementWenxin Ou, Honghao Ma, Ang Wei, et al.
Pediatric Blood & Cancer|April 22, 2022
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 yearsJeremie H Estepp, Ram Kalpatthi, Gerald Woods, et al.
Pageof 877